Aflibercept 8 mg administered every 12 or 16 weeks demonstrated comparable improvements in best-corrected visual acuity and central subfield retinal thickness as 2-mg dose every 8 weeks in patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results